Tempest Therapeutics shareholders approve stock issuance for warrant exercises

Tempest Therapeutics, Inc.

Proposal 1 passed: 9,090,763 votes for issuance of up to 925,927 shares from Series A and B warrants (March 2026 private placement).
Proposal 2 passed: 9,091,165 votes for issuance of up to 2,344,828 shares from Common Warrants (November 2025 inducement).
Both proposals had ~9.09M for, ~398k against, ~18k abstentions at the June 18, 2026 special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.